Showing results (1341-1350 of 5,058) with videos related to
Sort By:
Pageof 506
Multiple Sclerosis and Related Disorders|October 23, 2017
The effect of alcohol and red wine consumption on clinical and MRI outcomes in multiple sclerosisCamilo Diaz-Cruz, Alicia S Chua, Muhammad Taimur Malik, et al.Multiple Sclerosis and Related Disorders|October 23, 2017
Gender differences among Chinese patients with neuromyelitis optica spectrum disordersHui Sun, Xuan Sun, Jie Li, et al.Multiple Sclerosis and Related Disorders|October 23, 2017
PER3 VNTR polymorphism in Multiple Sclerosis: A new insight to impact of sleep disturbances in MSMasoud Golalipour, Zahra Maleki, Touraj Farazmandfar, et al.Multiple Sclerosis and Related Disorders|October 23, 2017
Chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids (CLIPPERS): A pediatric case report with six year follow-upAravindhan Veerapandiyan, Amit Chaudhari, Prabhav Deo, et al.Multiple Sclerosis and Related Disorders|July 25, 2022
Prognostic factors for functional recovery in children with moderate to severe acute disseminated encephalomyelitisLi-Wen Chen, Ju-Fang Cheng, Tung-Ming Chang, et al.Multiple Sclerosis and Related Disorders|July 20, 2022
Fulminant neuromyelitis optica spectrum disorder (NMOSD) following COVID-19 vaccination: A need for reconsideration?Ali Motahharynia, Saba Naghavi, Vahid Shaygannejad, et al.Multiple Sclerosis and Related Disorders|July 17, 2022
Assessment of economic burden of fatigue in adults with multiple sclerosis: An analysis of US National Health and Wellness Survey dataHoa H Le, Jennifer Ken-Opurum, Anne LaPrade, et al.Multiple Sclerosis and Related Disorders|July 21, 2022
Oligoclonal bands, age 11-17 years, occipital lesion, and female sex differentiate pediatric multiple sclerosis from acute disseminated encephalomyelitis: A nationwide cohort studyMagnus Spangsberg Boesen, Annika Reynberg Langkilde, Jurgita Ilginiene, et al.Multiple Sclerosis and Related Disorders|July 17, 2022
Evaluation of functional outcome measures after fampridine treatment in patients with multiple sclerosis - An interventional follow-up studyCecilie Dollerup Skov, Christina Borgen Sørensen, Maria Thorning, et al.Multiple Sclerosis and Related Disorders|July 17, 2022
Comment on "prevalence and risk factors of dysphagia in patients with multiple sclerosis"Ramin Mahdipour, Masoomeh Hajipour, Mohammad-Ali Shahin, et al.Pageof 506